Roche Holding AG (RHHBY)
35.44
+0.15
(+0.43%)
USD |
OTCM |
Nov 22, 16:24
Roche Price to Book Value: 7.017 for Nov. 22, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 6.987 |
| November 20, 2024 | 6.955 |
| November 19, 2024 | 7.011 |
| November 18, 2024 | 7.062 |
| November 15, 2024 | 7.096 |
| November 14, 2024 | 7.155 |
| November 13, 2024 | 7.329 |
| November 12, 2024 | 7.395 |
| November 11, 2024 | 7.448 |
| November 08, 2024 | 7.446 |
| November 07, 2024 | 7.557 |
| November 06, 2024 | 7.478 |
| November 05, 2024 | 7.704 |
| November 04, 2024 | 7.806 |
| November 01, 2024 | 7.773 |
| October 31, 2024 | 7.684 |
| October 30, 2024 | 7.812 |
| October 29, 2024 | 7.890 |
| October 28, 2024 | 7.981 |
| October 25, 2024 | 8.032 |
| October 24, 2024 | 8.016 |
| October 23, 2024 | 7.959 |
| October 22, 2024 | 7.759 |
| October 21, 2024 | 7.801 |
| October 18, 2024 | 7.832 |
| Date | Value |
|---|---|
| October 17, 2024 | 7.739 |
| October 16, 2024 | 7.737 |
| October 15, 2024 | 7.793 |
| October 14, 2024 | 7.755 |
| October 11, 2024 | 7.757 |
| October 10, 2024 | 7.696 |
| October 09, 2024 | 7.605 |
| October 08, 2024 | 7.577 |
| October 07, 2024 | 7.521 |
| October 04, 2024 | 7.478 |
| October 03, 2024 | 7.579 |
| October 02, 2024 | 7.735 |
| October 01, 2024 | 7.769 |
| September 30, 2024 | 7.910 |
| September 27, 2024 | 7.947 |
| September 26, 2024 | 7.951 |
| September 25, 2024 | 7.890 |
| September 24, 2024 | 7.910 |
| September 23, 2024 | 7.820 |
| September 20, 2024 | 7.810 |
| September 19, 2024 | 7.812 |
| September 18, 2024 | 7.842 |
| September 17, 2024 | 7.787 |
| September 16, 2024 | 7.763 |
| September 13, 2024 | 7.743 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
5.347
Minimum
May 02 2024
12.77
Maximum
Apr 08 2022
8.365
Average
8.258
Median
Price to Book Value Benchmarks
| Novo Nordisk AS | 25.87 |
| Pfizer Inc | 1.574 |
| Eli Lilly and Co | 49.85 |
| Novartis AG | 4.812 |
| Amgen Inc | 21.03 |
Price to Book Value Related Metrics
| PE Ratio | 19.20 |
| PS Ratio | 3.365 |
| Price to Free Cash Flow | 17.97 |
| Price | 35.44 |
| Earnings Yield | 5.21% |
| Market Cap | 225.91B |
| Operating PE Ratio | 13.90 |
| Normalized PE Ratio | 18.51 |